10x Genomics Inc (TXG) saw its stock price surge 9.94% during pre-market trading, indicating strong investor interest ahead of the regular session.
The significant price movement follows a series of positive analyst actions, with multiple financial institutions raising their target prices for the genomics company. Deutsche Bank increased its target to $17 from $16, JP Morgan raised to $17 from $15, Jefferies lifted to $21 from $17, Stifel boosted to $20 from $15, and TD Cowen moved to $19 from $18.
These coordinated analyst upgrades suggest growing optimism about 10x Genomics' business prospects and future performance, driving increased buying activity in the pre-market session.
Comments